Using T-ALL patient cells for validation, it was found that only SESN3 was significantly differentially expressed (upregulated) upon ATG4B silencing (n = 4, Fig. 3I), but not the other candidate transcripts. The gene discussed is ATG4B; the disease is acute lymphoblastic leukemia.